Ticker: NXTC

NextCure, Inc. (NASDAQ: NXTC) Overview: NextCure is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies using targeted mechanisms such as antibody-drug conjugates. The company has not generated revenue from product sales and is reliant on external funding ...